Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide in acute ischemic stroke with and without intravenous thrombolysis
ChiCTR2000038241Phase 4Recruiting
- Sponsor
- Department of Neurology, Shanghai Tenth People's Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of butylphthalide in ischemic stroke (4 arms), sponsored by Department of Neurology, Shanghai Tenth People's Hospital. Primary endpoints: Improvement of reperfusion volume in acute cerebral infarction, Increased infarct core volume and 1 more. Started Sep 2020; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000038241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038241.